Rhubarb

Rhubarb was used traditionally as a mild stimulating tonic to the digestive mucous membrane, liver and gall ducts. In smaller doses it was considered a hepatic and bitter; larger doses were used as a cathartic ^{27Reference 27Hoffmann · 2003Medical Herbalism: The Science and Practice of Herbal Medicine}.

Pinyin: Dà Huáng

Taste: Bitter ^{28,29Reference 28Yang et al. · 2013Introduction to Chinese Materia Medica (3rd ed., ppReference 29Wu · 2005An Illustrated Chinese Materia Medica}

Energy: Cold ^{28,29Reference 28Yang et al. · 2013Introduction to Chinese Materia Medica (3rd ed., ppReference 29Wu · 2005An Illustrated Chinese Materia Medica}

Channels: Spleen, stomach, large intestine, liver, heart ^{29Reference 29Wu · 2005An Illustrated Chinese Materia Medica}

Actions: Purges heat and accumulations, loosens the bowels, promotes blood circulation, drains fire, removes blood stasis and invigorates blood ^{28,29Reference 28Yang et al. · 2013Introduction to Chinese Materia Medica (3rd ed., ppReference 29Wu · 2005An Illustrated Chinese Materia Medica}.

Indications: Constipation due to heat accumulation, accumulation in the intestine, abdominal pain, damp-heat jaundice, blood-heat haemorrhage, red eyes, sore throat, intestinal abscesses, swellings, sores and ulcers ^{28Reference 28Yang et al. · 2013Introduction to Chinese Materia Medica (3rd ed., pp}.

This is rhubarb’s strongest human indication. Three independent meta-analyses of randomised trials each found that adding crude rhubarb to conventional therapy improved outcomes: combined with a trypsin inhibitor it lowered mortality and shortened hospital stay across 16 RCTs (912 patients) ^{1Reference 1Hu et al. · 2018Meta-analysisRhubarb combined with trypsin inhibitor for severe acute pancreatitis: A systematic review and meta-analysis — systematic review, meta-analysis of RCTsView study →}; combined with somatostatin it cut total complications (risk ratio 0.55) and APACHE II scores across 19 RCTs (1,161 patients) ^{2Reference 2Zhou et al. · 2016Meta-analysisAdd-on effect of crude rhubarb to somatostatin for acute pancreatitis: A meta-analysis of randomised controlled trials — meta-analysis, RCTView study →}; and combined with early enteral nutrition it shortened ICU and hospital stay across 11 RCTs (724 patients) ^{3Reference 3Chen et al. · 2020Meta-analysisMeta-analysis of efficacy of rhubarb combined with early enteral nutrition for the treatment of severe acute pancreatitis — meta-analysis, RCTView study →}. A representative single RCT (n=126) showed the rhubarb-plus-enteral-nutrition group recovered bowel function fastest and had the shortest ICU stay, alongside lower IL-6 and C-reactive protein ^{4Reference 4Wan et al. · 2014RCTEfficacy of rhubarb combined with early enteral nutrition for the treatment of severe acute pancreatitis: a randomised controlled trial — randomised, RCTView study →}. The mechanism is plausibly a combination of restored gut motility, reduced bacterial translocation and dampened systemic inflammation. The honest limits: rhubarb is always an add-on rather than a standalone treatment, nearly all trials are Chinese and of variable methodological quality, and the preparation is crude rhubarb (decoction or nasogastric slurry), not a bitter tincture.

Gap: No trial tests rhubarb against placebo alone or reports it as monotherapy, and trial quality (blinding, allocation concealment) is generally low — so the effect size is likely inflated.

The purgative action is the best-understood thing rhubarb does. Its anthraquinones — chiefly rhein, emodin and aloe-emodin, occurring free and as glycosides such as sennoside A — stimulate colonic motility and inhibit water/electrolyte reabsorption, an effect that typically takes 8–14 hours to appear ^{6,7Reference 6Tsai et al. · 2004AnimalEffect of ethanol extracts of three Chinese medicinal plants with laxative properties on ion transport of the rat intestinal epithelia — animal, in vivoView study →Reference 7Li et al. · 2017AnimalPharmacokinetics and pharmacodynamics of rhubarb anthraquinones extract in normal and disease rats — animal, in vivoView study →}. In a rat model, an ethanol extract of R. palmatum directly altered Na⁺ and Cl⁻ transport across the ileal epithelium, confirming a secretory component to the laxative effect ^{6Reference 6Tsai et al. · 2004AnimalEffect of ethanol extracts of three Chinese medicinal plants with laxative properties on ion transport of the rat intestinal epithelia — animal, in vivoView study →}. Human evidence now exists: a 30-day double-blind, placebo-controlled trial of a rhein-standardised rhubarb extract (12.5 and 25 mg rhein/day, mostly women, mean age 58) improved stool frequency and consistency and was well tolerated even at the higher dose, with changes tracking a shift in gut microbiota ^{5Reference 5Neyrinck et al. · 2022RCTConstipation mitigation by rhubarb extract in middle-aged adults is linked to gut microbiome modulation: A double-blind randomised placebo-controlled trial — randomised, placebo-controlled RCTView study →}. Because R. palmatum root is also unusually tannin-rich (~11%), small doses bind the stool and check diarrhoea while larger doses let the anthraquinones drive a purge — the classic dose-dependent reversal.

Gap: The one oral RCT was small and skewed female; there are no head-to-head trials against standard laxatives, and stimulant-laxative use raises the separate long-term-safety questions covered in Safety.

Rhein, rhubarb’s signature anthraquinone, is one of the more actively researched natural compounds in kidney disease. A systematic review and meta-analysis of animal studies concluded there is a significant association between rhein and improved outcomes in diabetic nephropathy models ^{8Reference 8Hu et al. · 2019Meta-analysisA significant association between rhein and diabetic nephropathy in animals: A systematic review and meta-analysis — systematic review, animal modelView study →}. Mechanistically, in an adenine-induced CKD mouse model rhein reversed loss of the anti-ageing protein Klotho by demethylating its promoter, protecting both kidney and bone ^{9Reference 9Zhang et al. · 2017AnimalRhein reverses Klotho repression via promoter demethylation and protects against kidney and bone injuries in mice with chronic kidney disease — mouse, in vivoView study →}. The one controlled clinical-style trial is veterinary: in cats with naturally occurring CKD, a Chinese rhubarb supplement (alone and with benazepril) was tested for slowing progression, the herb having documented antifibrotic properties attributed to TGF-β inhibition ^{10Reference 10Hanzlicek et al. · 2014RCTThe effect of Chinese rhubarb, Rheum officinale, with and without benazepril on the progression of naturally occurring chronic kidney disease in cats — randomised controlled trial (veterinary)View study →}. In people, the evidence remains indirect — a registered trial of rhubarb plus an ACE inhibitor for diabetic kidney disease was terminated (see Clinical trials).

Gap: No completed human RCT demonstrates a renal benefit; the strongest data are animal models and an isolated constituent (rhein) rather than the whole herb.

Rhubarb’s anti-inflammatory activity is largely the story of emodin. In animal models of severe acute pancreatitis with associated acute lung injury, emodin reduced inflammatory damage by suppressing NF-κB signalling, NLRP3-inflammasome activation and macrophage pyroptosis, in part by altering exosome-mediated cross-talk between the pancreas and lung ^{11Reference 11Hu et al. · 2022AnimalEmodin attenuates severe acute pancreatitis-associated acute lung injury by suppressing pancreatic exosome-mediated alveolar macrophage activation — rat, in vivoView study →}. This mechanistic thread plausibly underpins the clinical pancreatitis benefit above, and the same NF-κB/NLRP3 axis is invoked in rhubarb’s hepatoprotective work ^{15Reference 15Wu et al. · 2022AnimalRhubarb free anthraquinones improved mice non-alcoholic fatty liver disease by inhibiting NLRP3 inflammasome — mouse, in vivoView study →}. The evidence is coherent and mechanistically detailed but entirely preclinical — cell lines and rodents, using isolated emodin or anthraquinone fractions rather than the whole herb.

Gap: No human anti-inflammatory endpoint has been measured directly; the effect is inferred from animal models and a single constituent.

Rhubarb has a traditional and now trial-tested role in upper gastrointestinal bleeding. A systematic review and meta-analysis of 14 RCTs (1,493 patients) found that a rhubarb powder solution sprayed onto the bleeding site under gastroscope improved haemostasis in acute non-variceal upper GI bleeding compared with norepinephrine solution ^{12Reference 12Liu et al. · 2020Meta-analysisSpraying rhubarb powder solution under gastroscope in the treatment of acute non-variceal upper gastrointestinal bleeding: A systematic review and meta-analysis of randomised controlled trials — systematic review, meta-analysis, RCTView study →}. Separately, a large retrospective propensity-matched study (n=368) reported that rhubarb improved gastrointestinal function in critically ill patients with acute gastrointestinal injury, consistent with its known effects on the intestinal barrier and peristalsis ^{13Reference 13Zhang et al. · 2018ObservationalEffect of rhubarb on gastrointestinal dysfunction in critically ill patients: A retrospective study based on propensity score matching — observational, cohortView study →}. The astringent tannin fraction is the plausible basis for the topical styptic effect.

Gap: The bleeding trials use rhubarb as a locally sprayed powder during endoscopy — this does not transfer to oral or tincture use — and the critically-ill data are observational, not randomised.

Rhubarb’s liver effect is real but genuinely two-edged. In mice with non-alcoholic fatty liver disease, rhubarb free anthraquinones reduced hepatic inflammation by inhibiting the NLRP3 inflammasome ^{15Reference 15Wu et al. · 2022AnimalRhubarb free anthraquinones improved mice non-alcoholic fatty liver disease by inhibiting NLRP3 inflammasome — mouse, in vivoView study →}. But a metabolomic study in rats made the paradox explicit: the same R. palmatum extract was hepatoprotective at lower doses and hepatotoxic at higher ones, a pattern recognition problem the authors flagged directly ^{14Reference 14Wang et al. · 2011AnimalHepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury — rat, in vivoView study →}. This dose-dependence, plus the genotoxicity questions around emodin and aloe-emodin discussed in Safety, means “hepatoprotective” is only accurate within a narrow dose window.

Gap: No human liver-endpoint trial exists, and the protective-versus-toxic threshold is defined only in rodents — so the safe therapeutic margin in people is unknown.

Rhubarb’s anthraquinones are cytotoxic to cancer cells in culture. Emodin induces apoptosis and cell-cycle arrest across multiple cancer cell lines through several signalling pathways ^{16Reference 16Hsu et al. · 2012In vitroAnticancer potential of emodin — review, in vitroView study →}, and aloe-emodin triggered apoptosis, autophagy, sub-G1 arrest and mitochondrial-membrane collapse in human pancreatic adenocarcinoma cell lines ^{17Reference 17Du et al. · 2019In vitroAloe emodin exerts potent anticancer effects in MIAPaCa-2 and PANC-1 human pancreatic adenocarcinoma cell lines through activation of both apoptotic and autophagic pathways — in vitroView study →}. These are consistent in vitro findings for isolated molecules, but the concentrations used, the lack of any whole-herb or in vivo tumour data of quality, and emodin’s own genotoxicity ^{18Reference 18Akkol et al. · 2021ReviewIs emodin with anticancer effects completely innocent? Two sides of the coin — reviewView study →} all argue for treating this as a lead for drug development rather than a use for the herb.

Gap: All data are cell-line based with isolated constituents; there is no animal tumour model of quality or any human data, and the active molecules are themselves flagged for genotoxic risk.

Rhubarb has documented in vitro antimicrobial activity — against bacteria, against the amoeba Entamoeba histolytica ^{24Reference 24Espinosa et al. · 2020In vitroAnti-amebic effects of Chinese rhubarb (Rheum palmatum) root against Entamoeba histolytica — in vitroView study →}, and against cariogenic (tooth-decay) organisms ^{25Reference 25Song et al. · 2006In vitroIn vitro anti-cariogenic activity of dichloromethane fraction from Rheum undulatum — in vitroView study →} — consistent with its long traditional use for intestinal infection and “damp-heat”. The anthraquinones and tannins are the presumed actives. This remains laboratory-stage: there are no clinical trials of rhubarb as an antimicrobial, and in vitro potency rarely predicts effect at the concentrations achievable in the gut or bloodstream.

Gap: Evidence is entirely in vitro and often uses related Rheum species or solvent fractions rather than the whole root; no clinical antimicrobial data exist.

A single rat study reported that rhubarb attenuated blood–brain-barrier disruption after intracerebral haemorrhage, apparently by increasing expression of the tight-junction protein zonula occludens-1 ^{19Reference 19Wang et al. · 2016AnimalRhubarb attenuates blood-brain barrier disruption via increased zonula occludens-1 expression in a rat model of intracerebral haemorrhage — animal, in vivoView study →}. It is a plausible, mechanistically specific finding, but it is one animal study with no replication and no human follow-up. The page’s own suggestion that this could aid delivery of nervines or nootropics is speculation, not evidence.

Gap: One unreplicated rat study; no dose-finding, no other models, no human data.

Rhubarb root is a stimulant (anthraquinone) laxative and should be used short-term only. As with all anthranoid laxatives, prolonged or high-dose use can cause electrolyte loss — particularly potassium depletion — which may potentiate cardiac glycosides (e.g. digoxin) and antiarrhythmic drugs, and its accelerated intestinal transit can reduce absorption of co-administered medications ^{21Reference 21Siegers et al. · 1993ObservationalAnthranoid laxative abuse — a risk for colorectal cancer? — review, observationalView study →}. Chronic use produces melanosis coli, a benign reversible pigmentation of the colon; a causal link to colorectal cancer has been raised but is not established, and formal genotoxicity assessment of the anthranoids emodin and aloe-emodin found no convincing evidence of carcinogenic risk from ordinary laxative use ^{21,22,23Reference 21Siegers et al. · 1993ObservationalAnthranoid laxative abuse — a risk for colorectal cancer? — review, observationalView study →Reference 22Brusick et al. · 1997ReviewAssessment of the genotoxic risk from laxative senna products — reviewView study →Reference 23Yang et al. · 2020ReviewMelanosis coli: A comprehensive review — reviewView study →}. The root also contains oxalate: while serious oxalate toxicity is classically associated with the leaf blades (not the medicinal root or edible stalks), oxalosis has been documented with Rheum species, so avoid in people prone to calcium-oxalate kidney stones ^{20Reference 20Barceloux · 2009ReviewRhubarb and oxalosis (Rheum species) — reviewView study →}. Rhubarb leaves are poisonous and must never be eaten.

Drug interactions here are pharmacodynamic (potassium loss potentiating cardiac glycosides/antiarrhythmics, and reduced absorption via faster transit) rather than CYP450-mediated; no dedicated CYP450 interaction study for rhubarb was identified. These cautions matter mainly with prolonged or high-dose use, not occasional small bitter doses.